Prominent Democratic Senator Laughs at the Notion Regarding Marijuana’s Therapeutic Effects

Senator Dick Durbin of Illinois commented on marijuana during a Senate Judiciary Committee Hearing on the opioid epidemic.

He shared his state has decided to legalize marijuana for recreational use and added that “We’ve had medical marijuana. I’ve been to one of those clinics. It was almost a laughing matter.” He also stated, “The medical claims they make about marijuana go way beyond anything that’s been proven. There are no clinical trials going on.”

His comments prompted some backlash. NORMI political director Justin Strekal told Marijuana Moment,

“Senator Durbin’s comments surrounding the efficacy and therapeutic benefits of cannabis are ignorant at best and cruel at worst. There are over 30,000 peer-reviewed studies hosted on pubmed.gov on the effects of cannabis, including many showing declines in cases of opioid abuse and overdose fatalities.” He added, “If Mr. Durbin is serious about addressing the opioid crisis, then he ought not to disparage the role or lives saved that legal marijuana can play.”

The Enact Group’s principal, Michael Liszewski also shared with Marijuana Moment that although that marijuana’s designation as having Schedule I status has “prevented more robust” research into medical cannabis, it is still disappointing that the Senator Durbin characterized marijuana as a “laughing matter.”

He continued,

“To imply that patients need to look sick enough in order to obtain relief from medical cannabis ignores at least two points: First, many ailments that are treated by medical cannabis are not readily visible to observers, such as Crohn’s, lupus, and PTSD (all of which are qualifying conditions in Illinois). And second, it ignores the very real possibility that these individuals look healthy because their medical cannabis therapy is providing them with benefit.”

Additional viewpoints can be read in the Marijuana Moment article. At the end of the day, many use medical marijuana under their state’s guidelines and requirements to experience relief from a range of serious conditions.

Otto Baynes

Otto Baynes, a self-titled ‘great researcher’ with a Bachelor's Degree in Journalism, Linguistics, and Sociology, is one of the main core contributors at TOC to deliver daily news and fresh takeaways. It becomes very evident when consuming his cleverly-crafted content that his avid health and nutrition research skills are top shelf and are on full display. Watch Otto closely as Mr. Baynes plans to keep a pulse on the rapidly-evolving hemp and CBD industries.

Share

Recent Posts

  • Gummies

Condor CBD Gummies – Shocking Customer Scam Concerns?

The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…

2 years ago
  • Guides

Best Delta 8 THC Products – And Why You Need To Try Them

Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…

3 years ago
  • Guides

VidaCap: What To Know About the Best Mushroom Supplements Brand

With more people turning towards natural remedies in recent years, mushroom supplements have taken the…

3 years ago
  • Topicals & Salves

Circle Labs CBD: Legit Hemp Pain Relief Balm That Works?

The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…

3 years ago
  • Gummies

Kara’s Orchards CBD Gummies: Safe Full Spectrum Hemp Extract

If anyone is looking for a CBD supplement that is packed with all the necessary…

3 years ago
  • Tinctures & Drops

Sage Elixir CBD: Legit Sage Elixir CBD Oil Tincture or Not?

If anyone has been searching the internet for all the benefits of CBD and where…

3 years ago